[Creatine metabolism disorders in dermatomyositis, progressive scleroderma, visceral and cutaneous lupus erythematosus and panarteritis bodosa].
D000293:Adolescent; D000328:Adult; D000686:Amyloidosis / Q000150:complications; D003095:Collagen Diseases / Q000150:complications*; D003401:Creatine / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000652:urine; D003404:Creatinine / Q000652:urine; D003882:Dermatomyositis / Q000150:complications; D005260:Female; D006801:Humans; D008179:Lupus Erythematosus, Discoid / Q000150:complications; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008297:Male; D008659:Metabolic Diseases / Q000150:complications*; D008875:Middle Aged; D009136:Muscular Dystrophies / Q000150:complications; D010488:Polyarteritis Nodosa / Q000150:complications; D012595:Scleroderma, Systemic / Q000150:complications; D012871:Skin Diseases / Q000150:complications*
D003404:Creatinine; D003401:Creatine
Kreatinstoffwechselstörungen bei der Dermatomyositis, progressiven Sklerodermie, dem visceralen und cutanen Erythematodes und der Panarteriitis nodosa.